| Cash Flow | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Net income | 14,002.3 | 8,419.8 | 2,759.3 | 6,180.2 |
| Depreciation and amortization | 1,411.3 | 941.3 | 462.8 | 1,281.8 |
| Change in deferred income taxes | 958.9 | 1,460.3 | 391.6 | 1,716.4 |
| Stock-based compensation expense | 489.9 | 338.8 | 153.7 | 503.7 |
| Net investment losses | - | -35.3 | -149.1 | -29.8 |
| Gains on sale of product rights | - | - | - | 100.7 |
| Acquired in-process research and development | 2,381.2 | 1,725.5 | 1,571.7 | 3,091.2 |
| Other changes in operating assets and liabilities, net of acquisitions | 4,418.9 | 5,627.1 | 3,364.2 | 3,160.1 |
| Other operating activities, net | 681.5 | 379.2 | 324.8 | 234.6 |
| Net cash provided by operating activities | 13,588.4 | 4,752.5 | 1,665.6 | 6,344.1 |
| Purchases of property and equipment | 5,294.3 | 3,206.6 | 1,509.5 | 3,561.8 |
| Proceeds from sales and maturities of short-term investments | - | - | - | 107.3 |
| Purchases of short-term investments | - | - | - | 68.6 |
| Proceeds from sales of and distributions from noncurrent investments | 832 | 275.9 | 71.6 | 318 |
| Purchases of noncurrent investments | 518 | 367.9 | 196.7 | 525.1 |
| Proceeds from sale of product rights | - | - | - | 530.9 |
| Cash paid for acquisitions, net of cash acquired | 549.4 | 0 | - | 947.7 |
| Purchases of in-process research and development | 2,584.3 | 1,863.8 | 1,757 | 3,094.6 |
| Other investing activities, net | 55.8 | 24.8 | -39.3 | 139.4 |
| Net cash used for investing activities | -8,169.8 | -5,187.2 | -3,352.3 | -7,381 |
| Dividends paid | 4,038.5 | 2,693.3 | 1,346.3 | 3,512.1 |
| Net change in short-term borrowings | -4,337.6 | -245.9 | -1,848.7 | -4,894.1 |
| Proceeds from issuance of long-term debt | 13,167.2 | 6,461 | 6,461 | 11,417.1 |
| Repayments of long-term debt | 778.1 | 778.1 | - | 664.2 |
| Purchases of common stock | 2,600.3 | 1,892.2 | 1,200 | 446.1 |
| Other financing activities, net | -746.9 | -716.7 | -686.3 | -445.1 |
| Net cash provided by financing activities | 665.8 | 134.8 | 1,379.7 | 1,455.5 |
| Effect of exchange rate changes on cash and cash equivalents | 439.1 | 407.4 | 131.9 | 131.8 |
| Net increase in cash and cash equivalents | 6,523.5 | 107.5 | -175.1 | 550.4 |
| Cash and cash equivalents at beginning of period | 3,268.4 | 3,268.4 | 3,268.4 | 2,818.6 |
| Cash and cash equivalents at end of period | 9,791.9 | 3,375.9 | 3,093.3 | 3,369 |
ELI LILLY & Co (LLY)
ELI LILLY & Co (LLY)